Finally a cure?

Alzheimer; News from the web:

By the close of this year, the Indianapolis-based Fortune 500 pharmaceutical company Lilly , whose products have included the antidepressant Prozac and human insulin, will release the results of Expedition 3, a study testing a drug that targets amyloid in persons with mild stage dementia caused by Alzheimer’s disease. Its subjects are unique. They don’t simply have Alzheimer’s disease diagnosed by a careful history and exam. They have a brain scan showing amyloid accumulation.

Read all about it HERE

Early warning signs

Alzheimer; News from the web:

Always an important topic and it can not hurt to remind you again of the early signs that can point to dementia or developing Alzheimer.

Read all about it HERE

Power outage causes Alzheimer’s?

Alzheimer; News from the web:

In new research appearing in the journal Alzheimer’s and Dementia, Diego Mastroeni, Paul Coleman and their colleagues at the ASU-Banner Neurodegenerative Disease Research Center (NDRC) and the Biodesign Center for Bioenergetics investigate the role of mitochondria in Alzheimer’s disease pathology. Mitochondria act as energy centers for cells and are of central importance in health and disease.

The study builds on earlier work suggesting gene mutations affecting may be critical in the development— and pitiless progression— of the disease.

Read all about it HERE

For brain screening, check my eyes.

Alzheimer; News from the web:

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye. Research from the University of Eastern Finland (UEF) shows that retinal changes may be detected earlier than brain changes. Findings from mouse models suggest that eye examination could be used as a noninvasive screening tool for human brain diseases.

Read all about it HERE

Alzheimer’s predicted by genes!

Alzheimer; News from the web:

The great majority of people will eventually develop Alzheimer’s if they don’t die of something else first.

“That’s a fundamental insight that is different in this than in other studies out there — so-called polygenic risk scores, where you look at the disease as either something you’re going to get or not,”

Read all about it HERE